PrednisoneKidneyVincristineKidney TransplantationKidney DiseasesCyclophosphamideGlucocorticoidsKidney TubulesDoxorubicinProcarbazineAntineoplastic Combined Chemotherapy ProtocolsKidney CortexImmunosuppressive AgentsMechlorethamineAzathioprinePrednisoloneKidney Failure, ChronicAcute Kidney InjuryTreatment OutcomeMelphalanDrug Therapy, CombinationMitoxantroneAntibodies, Monoclonal, Murine-DerivedKidney Function TestsPolycystic Kidney DiseasesKidney GlomerulusKidney NeoplasmsAnti-Inflammatory AgentsDrug Administration ScheduleKidney Tubules, ProximalBleomycinKidney MedullaMethotrexateCyclosporineColor TherapyGraft RejectionRemission InductionTime FactorsChlorambucilMycophenolic AcidLymphoma, Non-HodgkinFollow-Up StudiesKidney CalculiHodgkin DiseaseLymphoma, Large B-Cell, DiffuseAdministration, OralKidney Tubules, CollectingAdrenal Cortex HormonesPolycystic Kidney, Autosomal DominantGraft SurvivalVinblastineTacrolimusAsparaginaseMultiple MyelomaThalidomideSurvival AnalysisGlomerular Filtration RateSurvival RateEtoposideNephrotic SyndromeRecurrenceRetrospective StudiesCreatinineProteinuriaDisease-Free SurvivalProspective StudiesMethylprednisolonePrognosisDose-Response Relationship, DrugCombined Modality TherapyKidney Diseases, CysticKidney Concentrating AbilityCyclosporinsChronic DiseaseImmunosuppressionKidney Tubules, Distal6-MercaptopurineClinical Trials as TopicPolymyalgia RheumaticaEtiocholanoloneDogsLymphoma, FollicularDisease ProgressionVindesineCarmustineDouble-Blind MethodAndrostenolsAntibodies, MonoclonalTaxoidsDexamethasoneNephrectomyBiopsyCapillary FragilityNephronsRisk FactorsBoronic AcidsPyrazinesLomustineEstramustinePrecursor Cell Lymphoblastic Leukemia-Lymphoma